Frédéric Guerin Selected Research

Subcutaneous panniculitis-like T-cell lymphoma

1/2020	Efficacy of ruxolitinib in subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis.
12/2018	Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Frédéric Guerin Research Topics

Disease

2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020 - 12/2018
2	Subcutaneous panniculitis-like T-cell lymphoma 01/2020 - 12/2018
1	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2019
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2018

Drug/Important Bio-Agent (IBA)

1	ruxolitinibIBA 01/2020
1	Biological ProductsIBA 01/2019
1	Mucin-3IBA 12/2018
1	Immunoglobulins (Immunoglobulin)IBA 12/2018